Business
Shih-Feng Chiu, MPH, Christina M. L. Kelton, PhD, Jeff Jianfei Guo, BPharm, PhD, Patricia R. Wigle, PharmD, Alex C. Lin, PhD, Sheryl L. Szeinbach, PhD, RPh
Michael Naslund, MD, MBA, Michael Eaddy, PharmD, PhD, Susan L. Hogue, PharmD, MPH, Eric J. Kruep, PharmD, MS, Manan B. Shah, PharmD, PhD
Benefit Management Considerations for BPH Medications: Single Agent or Combination Therapy?
Eric Q. Wu, PhD, Paul E. Greenberg, MA, Rym Ben-Hamadi, MSc, Andrew P. Yu, PhD, Elaine H. Yang, PhD, M. Haim Erder, PhD
Efficacy and Cost-Effectiveness: Escitalopram versus Citalopram
Re-Engineering the Healthcare Continuum: Implementing Value-Based Insurance Design to Improve Diabetes Management
New Strategies Needed to Combat Increasing Costs and Optimize Use of Infused Therapies
Anna O. D’Souza, PhD, Beth Common, MBA, Roshan Rahnama, MPH, Steven Burch, PhD, Timothy S. Regan, BPharm, RPh
Value-Based Insurance Design: Evolving Strategies to Improve Medication Adherence, Control Healthcare Utilization
Aligning Stakeholders Can Maximize the Opportunity for Cost-Savings on Drugs